Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC [0.03%]
异基因造血干细胞移植后骨髓增生异常综合征患者并发症评估体系：SFGM-TC研究结果
Alexis Caulier,Elodie Drumez,Jordan Gauthier et al.
Alexis Caulier et al.
Purpose: We developed a prognostic scoring system to evaluate the prognosis of myelodysplastic syndrome (MDS) patients surviving more than 100 days allogeneic hematopoietic cell transplantation after (allo-HCT). ...
Randomized Controlled Trial
Current research in translational medicine. 2019 Feb;67(1):8-15. DOI:10.1016/j.retram.2018.08.003 2019
Acute polyradiculopathy secondary to idelalisib in Relapsed Classical Hodgkin's lymphoma [0.03%]
复发性经典型霍奇金淋巴瘤接受Idelalisib治疗继发急性多神经根病
S Barbieux,E M Boyle,C Baillet et al.
S Barbieux et al.
Patients with relapsed or refractory Hodgkin's lymphoma are likely incurable with standard treatment. Idelalisib, a delta-isoform specific Phosphatidyl-inositol-3-kinase (PI3K) inhibitor has shown its efficacy in other hematopoietic B malig...
Schnitzler syndrome co-occurring with idiopathic multicentric Castleman disease that responds to anti-IL-1 therapy: A case report and clue to pathophysiology [0.03%]
Schnitzler综合征伴发的特发性多中心Castleman病对Anti-IL-1治疗有反应：一例报道及对发病机制的启示
Simon Soudet,David Fajgenbaum,Claire Delattre et al.
Simon Soudet et al.
Patients with HHV-8-negative/idiopathic multicentric Castleman disease (iMCD) experience systemic inflammatory symptoms and polyclonal lymphoproliferation due to an unknown etiology. Schnitzler's syndrome (SS) is characterized by recurrent ...
Association between Type I interferon and depletion and dysfunction of endothelial progenitor cells in C57BL/6 mice deficient in both apolipoprotein E and Fas ligand [0.03%]
载脂蛋白E和fas配体双缺陷的C57BL/6小鼠1型干扰素与内皮前体细胞消耗及功能障碍的相关性研究
Linyu Geng,Shiying Wang,Xia Li et al.
Linyu Geng et al.
Patients with systemic lupus erythematosus (SLE) have a tremendously increased risk for cardiovascular disease (CVD), which could not be accounted in entirety by traditional Framingham risk factors. To study whether the accelerated atherosc...
Adipose tissue-derived mesenchymal stromal cells for clinical application: An efficient isolation approach [0.03%]
用于临床应用的脂肪组织来源的间充质干细胞：一种有效的分离方法
D Lisini,S Nava,S Pogliani et al.
D Lisini et al.
Purpose of the study: Mesenchymal stromal cells (MSCs) are considered a promising tool for cell therapy approaches. The translation of research-based cell culture protocols into procedures that comply with Good Manufactur...
Clonal evolution of myelofibrosis treated with hematopoietic transplantation, using RUXOLITINIB for chronic GvHD: A case report [0.03%]
异基因造血干细胞移植后应用鲁索利替尼治疗慢性移植物抗宿主病患者的骨髓纤维化克隆演化：1例报告
L Fouillet,E Daguenet,F Schein et al.
L Fouillet et al.
Deciphering the mutational patterns and/or the biomarkers that might predict clinical response in patients with myelofibrosis is primordial to make treatment decisions. In this report, we discuss the clinical history, pathological evaluatio...
CRISPR/Cas9 genome editing: Fueling the revolution in cancer immunotherapy [0.03%]
CRISPR/Cas9基因组编辑：推动癌症免疫疗法革命的力量
Xiaojun Liu,Yangbing Zhao
Xiaojun Liu
The development of genomic editing technologies expands the landscape of T cell engineering for adoptive cell therapy. Among the multiple tools that can be used, CRISPR/Cas9 has been shown to be relatively easy to use, simple to design and ...
Bruno Quesnel
Bruno Quesnel
Clinical units to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Based on the recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) [0.03%]
嵌合抗原受体T细胞治疗(CAR-T cells)的临床开展单位：基于法语区骨髓移植和细胞治疗协会（SFGM-TC）的建议
Ibrahim Yakoub-Agha
Ibrahim Yakoub-Agha
The Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) hold its eighth practice harmonization workshops on September 2017. In a workshop dedicated to chimeric antigen receptor T-cell therapy (CAR T-cells), the...